Decoding Microbiota in Genitourinary Oncology: Biological Mechanisms and Clinical Implications—A Narrative Review
Open Access
Abstract
Genitourinary malignancies are characterized by marked heterogeneity in tumor biology, clinical behavior and therapeutic outcomes. Despite significant progress in surgical and systemic treatments, resistance to therapy remains a major challenge, highlighting the need to identify additional host-related determinants of disease progression and treatment response. Within this framework, converging experimental and clinical evidence indicates that host-associated microbial ecosystems may influence key biological processes involved in tumor–host interactions, including immune modulation, metabolic regulation and inflammatory pathways. Altered microbial profiles have been associated with oncogenic signaling, changes in the tumor microenvironment and differences in clinical benefit from systemic therapies, particularly immunotherapeutic approaches. This review brings together preclinical, translational and clinical evidence on the involvement of microbiota in renal, prostate, bladder and testicular cancers, with attention to biological mechanisms and clinically meaningful correlations with disease characteristics. While current data are largely observational, early interventional studies suggest that modulation of microbial ecosystems may influence therapeutic activity in selected clinical settings. Collectively, these findings support microbiota as a relevant component of genitourinary cancer biology with potential implications for precision medicine approaches.Keywords
This publication has 92 references indexed in Scilit:
- Research progress on intratumoral microorganisms in renal cancerWorld Journal of Urology, 2025
- The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapyBest Practice & Research Clinical Gastroenterology, 2024
- Causal relationship between gut microbiota and prostate cancer contributes to the gut-prostate axis: insights from a Mendelian randomization studyDiscover Oncology, 2024
- The microbiota and renal cell carcinomaCellular Oncology, 2023
- Microbiota and cancer: current understanding and mechanistic implicationsClinical and Translational Oncology, 2021
- Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencingJournal of Cancer Research and Clinical Oncology, 2020
- Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literatureCancer Immunology, Immunotherapy, 2020
- Prostate cancer progression and mortality: a review of diet and lifestyle factorsWorld Journal of Urology, 2016
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial MetabolitesCell, 2016
- Pathogen Recognition and Innate ImmunityCell, 2006